CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-15 | Erdtmann Rainer M President & COO | Purchase | +176,470 | $17.00 | $3.0M | 176,470 |
| 2021-04-15 | Butler Thomas Andrew CEO | Purchase | +176,470 | $17.00 | $3.0M | 176,470 |
| 2021-04-15 | Cormorant Asset Management, LP Director | Grant or award · Stock Option (right to buy) | −28,911 | 28,911 | ||
| 2021-04-15 | AGUIAR ERIC Director | Grant or award · Stock Option (Right to Buy) | +28,911 | 28,911 | ||
| 2021-04-15 | Stergiopoulos Sotirios Director | Grant or award · Stock Option (Right to Buy) | +28,911 | 28,911 | ||
| 2021-04-15 | Hitchcock Michael J.M. Director | Grant or award · Stock Option (Right to Buy) | +28,911 | 28,911 |
Page 6 of 6 · 106 trades